These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28211781)

  • 1. Post-therapeutic recovery of serum interleukin-35 level might predict positive response to immunosuppressive therapy in pediatric aplastic anemia.
    Huang Z; Tong H; Li Y; Zhou H; Qian J; Wang J; Ruan J
    Hematology; 2017 Aug; 22(7):430-436. PubMed ID: 28211781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Serum Interleukin-6 Predicts Favorable Response to Immunosuppressive Therapy in Children With Aplastic Anemia.
    Lu S; Qiao X; Xie X
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):614-617. PubMed ID: 29068868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markedly High Plasma Thrombopoietin (TPO) Level is a Predictor of Poor Response to Immunosuppressive Therapy in Children With Acquired Severe Aplastic Anemia.
    Elmahdi S; Muramatsu H; Narita A; Ismael O; Hama A; Nishio N; Okuno Y; Xu Y; Wang X; Takahashi Y; Kojima S
    Pediatr Blood Cancer; 2016 Apr; 63(4):659-64. PubMed ID: 26575027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between plasma rabbit anti-thymocyte globulin concentration and immunosuppressive therapy response in patients with severe aplastic anemia.
    Narita A; Muramatsu H; Ichikawa D; Hamada M; Nishikawa E; Suzuki K; Kawashima N; Okuno Y; Nishio N; Hama A; Yamazaki H; Nakao S; Kojima S; Takahashi Y
    Eur J Haematol; 2021 Aug; 107(2):255-264. PubMed ID: 33949001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 and interleukin-8 levels in children with aplastic anemia and its correlation with disease severity and response to immunosuppressive therapy.
    Singh A; Bhargawa SK; Yadav G; Kushwaha R; Verma SP; Tripathi T; Singh US; Tripathi AK
    Ann Afr Med; 2023; 22(4):446-450. PubMed ID: 38358144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 and Interleukin-8 Levels Correlate With the Severity of Aplastic Anemia in Children.
    Gupta V; Kumar S; Sonowal R; Singh SK
    J Pediatr Hematol Oncol; 2017 Apr; 39(3):214-216. PubMed ID: 28060106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia?
    Song MK; Chung JS; Joo YD; Kim YS; Kim SH; Seol YM; Shin HJ; Choi YJ; Cho GJ
    Eur J Haematol; 2009 Jul; 83(1):72-8. PubMed ID: 19220415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic efficacy evaluation of rabbit anti-thymocyte globulin combined with cyclosporine A in children with aplastic anemia].
    Fu RT; Xue HM; Xu HG; Huang K; Fang JP; Huang SL; Chen C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):426-30. PubMed ID: 23628047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical implications of combined measurement bone marrow T cells intracellular IFNgamma and HLA-DRB1*1501 measurement in predicting the response to immunosuppressive therapy for aplastic anemia].
    Chen Y; Xu CG; Guo NJ; Huang P; Xiao DJ; Ding BT; Ge LF
    Zhonghua Nei Ke Za Zhi; 2007 Oct; 46(10):846-9. PubMed ID: 18218241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of paroxysmal nocturnal hemoglobinuria clones in response to immunosuppressive therapy of patients with severe aplastic anemia.
    Zhao X; Zhang L; Jing L; Zhou K; Li Y; Peng G; Ye L; Li Y; Li J; Fan H; Song L; Yang W; Zhang F
    Ann Hematol; 2015 Jul; 94(7):1105-10. PubMed ID: 25784221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on the predictors of response to immunosuppressive therapy in severe aplastic anemia patients].
    Mu XY; Chang H; Liu T; Gong YP; Niu T; Qin H; Ma HB; Meng WT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):897-900. PubMed ID: 19950609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
    Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): an initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC).
    Williams DA; Bennett C; Bertuch A; Bessler M; Coates T; Corey S; Dror Y; Huang J; Lipton J; Olson TS; Reiss UM; Rogers ZR; Sieff C; Vlachos A; Walkovich K; Wang W; Shimamura A
    Pediatr Blood Cancer; 2014 May; 61(5):869-74. PubMed ID: 24285674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of pediatric acquired aplastic anemia: a developing world experience.
    Ramzan M; Yadav SP; Zafar MS; Dinand V; Sachdeva A
    Pediatr Hematol Oncol; 2014 Feb; 31(1):29-38. PubMed ID: 23802844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Cytokine-Based Diagnostic Program in Pediatric Aplastic Anemia and Hypocellular Refractory Cytopenia of Childhood.
    Elmahdi S; Hama A; Manabe A; Hasegawa D; Muramatsu H; Narita A; Nishio N; Ismael O; Kawashima N; Okuno Y; Xu Y; Wang X; Takahashi Y; Ito M; Kojima S
    Pediatr Blood Cancer; 2016 Apr; 63(4):652-8. PubMed ID: 26485171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate logistic analysis of predictors of response to immunosuppressive therapy in children with aplastic anemia: a double-center study.
    Gu C; Zhu X; Qiao X; Zhai X; Shi W; Xie X
    Hematology; 2019 Dec; 24(1):282-289. PubMed ID: 31793407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biological characteristics of bone marrow-derived mesenchymal stem cells and their relationship with immunosuppressive therapy in children with aplastic anemia].
    Huang YL; Huang SL; Huang K; Cai Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):9-13. PubMed ID: 18289461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes in adult patients with aplastic anemia: A single institution experience.
    Boddu P; Garcia-Manero G; Ravandi F; Borthakur G; Jabbour E; DiNardo C; Jain N; Daver N; Pemmaraju N; Anderlini P; Parmar S; Kc D; Akosile M; Pierce SA; Champlin R; Cortes J; Kantarjian H; Kadia T
    Am J Hematol; 2017 Dec; 92(12):1295-1302. PubMed ID: 28850699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A plasma microRNA signature as a biomarker for acquired aplastic anemia.
    Hosokawa K; Kajigaya S; Feng X; Desierto MJ; Fernandez Ibanez MD; Rios O; Weinstein B; Scheinberg P; Townsley DM; Young NS
    Haematologica; 2017 Jan; 102(1):69-78. PubMed ID: 27658437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.